Sign In

Enrique Samper

Ideologist, co-founder and CEO NIMGenetics. Innovator and team player in healthcare and research. I work with my team to improve healthcare through genomics. I am spartan from MSU at heart and we never give up!

Professional Background

Dr. Enrique Samper, Ph.D., is a distinguished entrepreneur and a pioneer in the field of clinical genomics as the CEO and co-founder of NIMGenetics, a rapidly growing scaleup company specializing in providing genomic services to healthcare professionals and patients. NIMGenetics stands out in the industry, consistently achieving double-digit year-on-year growth with a remarkable 10-year compound annual growth rate (CAGR) exceeding 20%. The company has established a robust presence across Spain, Mexico, Brazil, and Portugal, focused on expanding its outreach through strategic partnerships and distribution channels, thus enhancing access to innovative genomic solutions for an increasing number of patients.

Dr. Samper's professional journey reflects his commitment to putting patients and clients at the forefront of the company's mission, ensuring they receive the best possible support throughout their healthcare journey. With a deep passion for translating scientific knowledge in genetics into actionable services, he transitioned from a successful career in molecular biology research to entrepreneurship. His vision for NIMGenetics is to bridge the gap between cutting-edge scientific discoveries and real-world applications, benefitting a diverse array of stakeholders, including doctors and patients alike.

Dr. Samper has not only led NIMGenetics to success but has also secured significant funding for the organization, raising over €9 million in equity as well as €4 million in research grants and soft loans. This impressive track record demonstrates his capacity for building teams and attracting investors, with the belief that this is merely the beginning of an exciting journey filled with opportunities for growth and development in the healthcare and biotechnology sectors.

Education and Achievements

Dr. Enrique Samper’s educational background is both extensive and impressive. He earned his Ph.D. in Molecular Biology from the renowned Universidad Autónoma de Madrid, providing him with a strong foundation in the principles of genetics and molecular research. Following this, he obtained a Master’s degree in Plant Biotechnology from the University of London. His undergraduate studies culminated in a Bachelor of Science in Plant Physiology and Genetics from Michigan State University, equipping him with a comprehensive understanding of the biological sciences.

In addition to his scientific education, Dr. Samper has complemented his credentials with advanced studies in business and entrepreneurship. He participated in the esteemed Executive Joint Program in International Economics at Harvard Business School, which involved rigorous training in various aspects of global economics, essential for navigating the complexities of a globalized healthcare market. He also completed an Executive Growth Program at IESE Business School - University of Navarra, focusing on high-growth startups, where he was recognized as a national finalist, showcasing his innovative approach to business leadership.

Moreover, his commitment to lifelong learning and entrepreneurship is further highlighted by his attendance at various executive education programs, such as high-growth SMEs and entrepreneurship at ESADE Business & Law School and winning 1st place in the Banespyme Orange Startup Competition at IE Business School with his co-founders from NIMGenetics.

Key Achievements

Dr. Samper's career is marked by a series of commendable achievements that underscore his impact on the biotechnology field. As the former Ramón y Cajal Scientist and Junior Group Leader at the CNIC in Madrid, he significantly contributed to aging research, publishing pivotal findings that have shaped the understanding of molecular genetics.

He also served as a PostDoctoral and Staff Research Investigator at the Buck Institute for Age Research, where he honed his skills in a collaborative environment focused on aging and age-related diseases. Furthermore, he worked at the National Center for Biotechnology-CSIC in Madrid, Spain, where he completed vital research that helped clarify genetic mechanisms.

Under Dr. Samper's leadership, NIMGenetics has emerged as a frontrunner in clinical genomics, earning respect and recognition within the industry. The company continues to innovate and adapt, supporting the evolving needs of healthcare professionals and their patients.

Through his extensive experience, educational pursuits, and unwavering dedication to advancing genomic technologies, Dr. Enrique Samper exemplifies the spirit of entrepreneurship in the biotech field. His ongoing commitment to excellence and patient-centric solutions serves as a beacon for the future of healthcare implementation, ensuring that all stakeholders can benefit from the extraordinary advancements in genomics.

Related Questions

What inspired Dr. Enrique Samper to transition from a career in molecular biology to entrepreneurship in the biotechnology sector?
How has Dr. Enrique Samper’s educational background in molecular biology and business influenced his role as CEO of NIMGenetics?
What strategies has Dr. Enrique Samper employed to secure over €9 million in equity funding for NIMGenetics?
In what ways has Dr. Enrique Samper shaped the vision and mission of NIMGenetics to prioritize patient and client needs?
What are Dr. Enrique Samper's future aspirations for NIMGenetics as it looks to expand its footprint in the healthcare industry?
Enrique Samper
Add to my network

Location

Alcobendas, Community of Madrid, Spain